Skip to main content
Fig. 1 | BMC Medical Genomics

Fig. 1

From: Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma

Fig. 1

a Consort flow of study population. b Somatic mutation profiles of WES data. MYCN-amplified patients (n = 9), presented on the right side of the heatmap (purple), were compared with the non-amplified population. The top 20 frequently mutated genes (green bar) and 5 functional genes (orange bar) related to DNA mismatch repair or homologous recombination repair are listed. *TMB: Tumour Mutational Burden. c Comparison of incidence of mutation between MYCN-amplified and non-amplified groups

Back to article page

BMC Medical Genomics

ISSN: 1755-8794

Contact us